After opening its first headquarters in the Americas in Rio de Janeiro, the University of Oxford, in the United Kingdom, is structuring its first course in the country. It will be in global health, taught in partnership with the National Institute of Cardiology (INC). It will run for four weeks and is expected to begin in the second half of 2022.
The course is the first with national certification, offered by the INC through the Ministry of Education, and international, offered by the Universities of Oxford and Siena, in Italy. Coordinator of the Brazilian center at the University of Oxford, infectious disease specialist Sue Ann Clemens emphasizes the importance of cooperation between different scientific institutions.
“It is the first global health course in Brazil to be certified by renowned universities in Europe. It brings a unique meeting of Brazilian and international experts to discuss the subject in its different themes”, explains the researcher.
Registration details have not yet been released. But the coordinator says that a partnership link will be opened. The course is intended for all public health professionals and managers.
In addition to the extension, the British university, which developed one of the vaccines against Covid-19, produced by the Anglo-Swedish laboratory AstraZeneca, which transferred technology to Brazilian production at Fiocruz, will also participate in a research project coordinated by the INC, called from Renomica. The objective is to map hereditary vascular diseases in the Brazilian population.
The headquarters of the University of Oxford is located on Avenida Beira Mar, in downtown Rio, and has a permanent structure of 15 professionals, responsible for coordinating research at institutions in six Brazilian states.
Source: CNN Brasil